GlassScriptPhysician profile
Christina Dada
NPI 1962944660
$2,415.21
in general payments reported to CMS, 2019-2025
15 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.54 · 2023: $61.62 · 2024: $1,935 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,278 · Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,277.96 |
| Food and Beverage | $1,121.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,934.77 | 2024 | Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Astrazeneca Pharmaceuticals LP | $100.24 | 2025 | Airsupra |
| Electromed, INC. | $77.21 | 2025 | Smartvest |
| Harmony Biosciences LLC | $50.58 | 2025 | |
| Glaxosmithkline, LLC. | $38.27 | 2025 | Nucala, Trelegy Ellipta |
| Viatris Specialty LLC | $38.16 | 2025 | Yupelri |
| United Therapeutics Corporation | $23.92 | 2025 | Tyvaso |
| Merck Sharp & Dohme LLC | $23.16 | 2025 | Winrevair |
| Telix Pharmaceuticals | $22.93 | 2023 | Illuccix |
| Eisai INC. | $21.85 | 2023 | |
| Mallinckrodt Hospital Products INC. | $20.21 | 2025 | Acthar |
| Pulmonx Corporation | $16.95 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Jazz Pharmaceuticals INC. | $16.84 | 2023 | |
| Ethicon INC. | $15.54 | 2021 | |
| Lilly USA, LLC | $14.58 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Dada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.